Website
N/ATelephone
61.2.9159.3719
Address
Suite 404 309 George Street Sydney, New South Wales (NSW) 2000
Description
EchoIQ Ltd. engages in the development, marketing and commercialization of software, products and services. It develops and patents algorithm dealing in Prescriptive Analytics. The company was founded by Richard Charles Anstey on March 31, 2010 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.11 - 0.23
Trade Value (12mth)
AU$24,173.00
1 week
0%
1 month
-8.57%
YTD
-11.11%
1 year
-13.51%
All time high
3.02667
EPS 3 yr Growth
54.600%
EBITDA Margin
%
Operating Cashflow
-$5m
Free Cash Flow Return
-64.10%
ROIC
-107.30%
Interest Coverage
N/A
Quick Ratio
1.30
Shares on Issue (Fully Dilluted)
460m
HALO Sector
Mining
Next Company Report Date
29-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
Application for quotation of securities - EIQ
×
Application for quotation of securities - EIQ |
31 October 23 |
Cleansing Notice
×
Cleansing Notice |
31 March 23 |
Application for quotation of securities - EIQ
×
Application for quotation of securities - EIQ |
31 March 23 |
Cleansing Notice
×
Cleansing Notice |
31 January 23 |
Change of Auditor
×
Change of Auditor |
31 August 23 |
Preliminary Final Report
×
Preliminary Final Report |
31 August 22 |
New Research Presented at Leading Cardiology Conference
×
New Research Presented at Leading Cardiology Conference |
31 August 22 |
Preliminary Final Report
×
Preliminary Final Report |
30 September 22 |
Proposed issue of securities - EIQ
×
Proposed issue of securities - EIQ |
30 September 22 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 September 22 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
30 October 23 |
Ord Minnett Healthcare Forum
×
Ord Minnett Healthcare Forum |
30 November 23 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
30 November 22 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
30 March 23 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
29 November 23 |
Notification regarding unquoted securities - EIQ
×
Notification regarding unquoted securities - EIQ |
29 November 22 |
Pause in Trading
×
Pause in Trading |
29 November 22 |
Trading Halt
×
Trading Halt |
29 August 23 |
Paid Pilot with Australia's Largest Cardiology Provider
×
Paid Pilot with Australia's Largest Cardiology Provider |
28 September 23 |
Annual Report to shareholders
×
Annual Report to shareholders |
28 September 23 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
28 September 23 |
Cleansing Notice
×
Cleansing Notice |
28 September 22 |
mFund - Distribution Estimate - PML01 (PML-AU)
×
mFund - Distribution Estimate - PML01 (PML-AU) |
28 September 22 |
mFund - Distribution Estimate - PML02 (PML-AU)
×
mFund - Distribution Estimate - PML02 (PML-AU) |
28 October 22 |
Quarterly Activities/Appendix 4C Cash Flow Report - Sept
×
Quarterly Activities/Appendix 4C Cash Flow Report - Sept |
28 November 22 |
Results of Meeting
×
Results of Meeting |
28 June 23 |
Cleansing Notice
×
Cleansing Notice |
28 February 23 |
Appendix 4D 31 December 2022
×
Appendix 4D 31 December 2022 |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.